BioQ, Sophos Partner for Post-Operative Pain Management Therapy

BioQ Pharma Incorporated and Sophos Biotech, both specialty pharmaceutical companies, have entered a strategic partnership agreement in Italy, under which BioQ will supply and Sophos will commercialize a treatment for post-operative pain management.

The 48-hour post-surgical pain management therapy is a disposable, single-use infusion system, which is pre-filled at the point of manufacture with 0.2% Ropivacaine (a non-narcotic local anesthetic). The ready-to-use product is activated by a single touch and contains a unit-dose of the sterile drug.

“We are delighted to announce this new partnership with Sophos, an aggressive and nimble player in the Italian market,” said Josh Kriesel, President and CEO of BioQ Pharma. “Sophos’ experienced management team will be essential to our future success in this important European market”.